The Neurogenic Orthostatic Hypotension Market focuses on treatments for neurogenic orthostatic hypotension (nOH), a condition characterized by an abnormal drop in blood pressure when a person stands up due to impaired autonomic nervous system function. It can cause dizziness, lightheadedness, weakness, blurred vision, and fainting, potentially affecting daily activities and quality of life....
The acetylcholine market is shaped by its importance in neurotransmission and its use in pharmaceutical preparations and laboratory research. Growing interest in neurological mechanisms is encouraging researchers to investigate cholinergic pathways and receptor activity. By 2034, product quality, research requirements, and specialized healthcare applications are expected to remain important...
The global burden of dementia is increasing rapidly as populations age, creating an urgent need for more effective therapies and comprehensive patient care. Among the various forms of dementia, Lewy body dementia (LBD) is one of the most complex neurodegenerative disorders, characterized by progressive cognitive decline, movement difficulties, sleep disturbances, and behavioral changes. The...
According to the latest report published by Data Bridge Market Research, the Dysautonomia Market
Data Bridge Market Research analyses a growth rate in the dysautonomia market in the forecast period 2023-2030. The expected CAGR of dysautonomia market is tend to be around 12% in the mentioned forecast period. The market was valued at USD 2708.03 million in 2022, and it would grow...